FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
Health News Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of…
You must be logged in to post a comment.